DiscoveRx Corporation Breaks the Barriers of Conventional Cell-Based Screening with Launch of a Powerful New InCELL Hunter™ Platform

FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx, a leader in innovative cell-based assays for GPCRs, Kinases, NHRs and Proteases, today unveiled a break-through technology called InCELL Hunter™. This platform marks a significant step forward as compared to other cell-based assay platforms currently available for Kinases, Epigenetics and other enzyme targets. This novel technology allows researchers to evaluate compound binding to a target of interest directly in a cellular environment.

Back to news